Skip to Content
About Us Become an Authorised Buyer Medical Partners Blog Contact Us
🌐Ship toSelect country
  1. All products
  2. Shop by Area
  3. Nasolabial folds
  4. Revolax Sub-Q Lidocaine - 1 x 1,1ml
  5. Nasolabial folds
Pricelist: Default Pricelist
Pricelist: Default Pricelist
Revolax Sub-Q Lidocaine - 1 x 1,1ml

Revolax Sub-Q Lidocaine - 1 x 1,1ml

Revolax Sub-Q is the thickest, most highly cross-linked product in the Revolax range (24mg/ml HA, 0.3% lidocaine), designed for subcutaneous implantation to volumise depressed facial areas and provide strong structural support. It is used for cheek, chin, nose and jawline augmentation and severe wrinkle correction, with reported results lasting up to 18 months; fully reversible with hyaluronidase if needed. For use by licensed, trained medical professionals only.

Cross-Linked Hyaluronic Acid Deep Wrinkles Lidocaine
37.95 € 37.95 €
  • Brand
Contact Us
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Revolax
SKU A8802 Share
Treatment Areas CheeksChinJawlineNasolabial foldsNose
Tags Cross-Linked Hyaluronic AcidDeep WrinklesLidocaine

Revolax Sub-Q is a high-viscosity cross-linked hyaluronic acid dermal filler manufactured by Across Co. (South Korea), formulated for deep subcutaneous injection to restore volume and contour in areas such as the cheeks and chin. Formulated with lidocaine for a more comfortable injection experience.

CONCENTRATION

  • Cross-linked hyaluronic acid (high viscosity)
  • Lidocaine hydrochloride

THE PACK INCLUDES

  • 1 x 1.1ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C

RESULTS & DURATION

Results typically last 12-15 months, depending on individual metabolism.

INDICATIONS

  • Loss of cheek and chin volume
  • Facial contouring

TREATMENT AREAS

  • Cheeks
  • Chin
  • Face, general

Revolax Sub-Q is injected into the deep dermis or subcutaneous plane using bolus or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin